Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Horner

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Cell|February 21, 2012
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastasesZhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, et al.
Cell|October 15, 2013
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cellsWilliam J Israelsen, Talya L Dayton, Shawn M Davidson, et al.
Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Cell|February 21, 2012
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastasesZhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, et al.
Cell|October 15, 2013
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cellsWilliam J Israelsen, Talya L Dayton, Shawn M Davidson, et al.
Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Pageof 3